What is the Impact Factor of Tuberculosis and Respiratory Diseases?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Tuberculosis and Respiratory Diseases is 3.60, ranking in quartile Q2 of Web of Science (ESCI).

Is Tuberculosis and Respiratory Diseases indexed in Web of Science or Scopus?

Yes, Tuberculosis and Respiratory Diseases is indexed in Web of Science (ESCI, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.798 (Q2) and an H-index of 41.

Who publishes Tuberculosis and Respiratory Diseases and what is the Article Processing Charge (APC)?

Tuberculosis and Respiratory Diseases is published by The Korean Academy of Tuberculosis and Respiratory Diseases. It operates under a Diamond Open Access model, exempting authors completely from Article Processing Charges ($0 USD APC).

WoS ESCI Q2Scopus Q2SCImago #6,943Diamond OAGold OA

Tuberculosis and Respiratory Diseases

Identifier (ISSN):1738-3536(Print)/2005-6184(Online)

•

Publisher:The Korean Academy of Tuberculosis and Respiratory Diseases

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

3.6↑ +0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Tuberculosis and Respiratory Diseases

WoS Q2

Annual Impact Factor Metric

Current (2026):3.6

Scopus SJR & RankScopus Q2

0.798

#6,943

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

41 papers with at least that number of citations each

WoS: ESCIQ2

Self-Citation Rate8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

34articles/year

100% Gold OA•69.44% Original Research

Aims & Scope

Tuberculosis and Respiratory Diseases (ISSN: 1738-3536) is a peer-reviewed international scholarly journal in the field of RESPIRATORY SYSTEM, published by The Korean Academy of Tuberculosis and Respiratory Diseases in Korea, Republic Of. The periodical holds a Journal Impact Factor (JIF) of 3.60, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 0.798 (Q2), an H-index of 41.

Topics Covered (Recognized by AI)

Medicine99.8%Internal medicine76.8%Biology69.5%Pathology69%Surgery46.3%Genetics41.1%Immunology32.8%Philosophy32%Radiology31.7%Linguistics31.4%Lung30.6%Tuberculosis30.3%Psychology26.8%Chemistry26.8%Psychiatry25.1%Biochemistry22.2%

Primary Research Areas

Respiratory System

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

RESPIRATORY SYSTEM

Rank31/107

IndexESCI

JCIESCI2026

RESPIRATORY SYSTEM

Rank44/107

IndexESCI

Category	Index	Rank	Quartile
RESPIRATORY SYSTEM	JCRESCI	31/107	Q2
RESPIRATORY SYSTEM	JCIESCI	44/107	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.6

Articles / Year22

Total Citations1

2025

IF3

Articles / Year80

Total Citations125

2024

IF2.5

Articles / Year60

Total Citations324

2023

IF2.9

Articles / Year44

Total Citations397

2022

IF—

Articles / Year37

Total Citations519

Year	Impact Factor	Articles / Year	Total Citations
2026	3.6	22	1
2025	3	80	125
2024	2.5	60	324
2023	2.9	44	397
2022	—	37	519
2021	—	51	450
2020	—	58	1,155
2019	—	34	487
2018	—	65	1,596
2017	—	60	1,110
2016	—	43	1,397
2015	—	84	1,605

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,943Scopus Q2Diamond OASCImago Profile

Scopus Coverage:1980-2025

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.798

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.98

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations431

3-Year Documents137

Citable Documents119

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate37.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ2

Pulmonary and Respiratory MedicineQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区RESPIRATORY SYSTEM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 34 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.